Introduction
============

Schizophrenia is a highly heritable brain disorder. Twin and family studies have demonstrated that genetic liability for SZ is strong (0.6--0.7; Saha et al., [@B53]) and several candidate genes have been identified (Brenner et al., [@B4]). A candidate gene previously identified in this context, namely disrupted-in-schizophrenia 1 (DISC1), was originally discovered at the breakpoint of a chromosomal translocation *t*(1; 11) (q42.1; q14.3) that segregated with schizophrenia, bipolar disorder, and major depression in a large Scottish family (Millar et al., [@B43]; Blackwood et al., [@B1]). After this initial finding, several other genetic linkage studies associated DISC1 with a number of different forms of mental illness; including schizophrenia (Chubb et al., [@B13]), schizoffective disorder (Hodgkinson et al., [@B32]), bipolar disorder (Hennah et al., [@B29]), and autism spectrum disorders (Kilpinen et al., [@B34]; Williams et al., [@B61]). There have also been additional associations in individuals with specific cognitive profiles such as long- and short-term memory (Cannon et al., [@B6]), visual memory in families with high densities of schizophrenia (Hennah et al., [@B30]), hippocampal structure and function (Callicott et al., [@B5]), psychosis-related personality traits in healthy control populations (Tomppo et al., [@B58]), and even subtle differences in healthy cognitive aging (Thomson et al., [@B57]; Harris et al., [@B27]).

Mutagenized mice have provided significant information regarding the role of DISC1 in healthy development and maturation. In DISC1 transgenic mice there is evidence of a reduction in neuron number, decreased neurogenesis, altered neuronal morphology, depressive- and schizophrenia-like behavioral phenotypes, and reduced regional brain volumes (Clapcote et al., [@B14]; Lee et al., [@B37]). In humans, DISC1 has been shown to have a strong modulatory effect on frontal-temporal cortical development (Carless et al., [@B7]; Raznahan et al., [@B49]) and thinning of the prefrontal cortex (Szeszko et al., [@B56]) and the left supramarginal gyrus (Brauns et al., [@B3]). To date, no studies have explicitly focused on the analysis of the relationship between subcortical structures in the human and DISC1. However, evidence from the animal literature suggests that DISC1 may effect the proportion of dopamine receptors located in the striatum, providing an intriguing risk mechanism that may be a final common pathway for several mental disorders. Lipina et al. ([@B40]) demonstrate DISC1 is related to a 2.1-fold increase in the proportion of striatal dopamine receptors without a significant change in dopamine release in the DISC1-L100P mutant (Clapcote et al., [@B14]).

Two single nucleotide polymorphisms (SNP) are studied here, specifically Leu607Phe (rs6675281) and Ser704Cys (rs821618). These SNPs were chosen as both the Phe and Ser alleles have been previously linked to increased risk for mental illness. Specifically, Raznahan et al. ([@B49]) demonstrated cortical thinning associated with both of these alleles and Szeszko et al. ([@B56]) showed reduction in the superior frontal gyrus and anterior cingulate gyrus in Phe carriers. Based on these findings and the previous striatum-related finding in the animal model literature we hypothesized that the striatum is one of the neuroanatomical substrates through which DISC1 elevates risk for mental illness. Here, we study this hypothesis using a cohort of healthy control individuals and use automated image processing techniques to accurately identify subcortical structures (Chakravarty et al., [@B8], [@B11]). We also performed an exploratory analysis to better understand the relationship of DISC1 with cortical thickness and cortical surface area.

Materials and Methods
=====================

Study participants
------------------

Fifty-four healthy Caucasian volunteers were recruited for this study (33 male and 21 female; mean age: 33.5; standard deviation of age: 10.0; age range: 18--55 years old). All subjects were right handed and had no history of a mental disorder. None of the participants were currently abusing substance nor had any previous history of substance abuse, a positive toxicological screening result, a history of head trauma with loss of consciousness or seizure (or other neurological disorder), and had no first-degree relative with a history of a psychotic mental disorder. All subjects were assessed with the Edinburgh handedness inventory (Oldfield, [@B45]), Wechsler Test for Adult Reading for IQ, and Hollingshead index for socio-economic status. They were also interviewed by a psychiatrist, completed the structured interview for *DSM-IV* disorders (First et al., [@B19]) and the Mini-Mental State Examination (Folstein et al., [@B20]), and completed a urine toxicology exam. The study was approved by the Research Ethics Board of the Centre for Addiction and Mental Health (Toronto, ON, Canada), and all participants provided informed, written consent.

Genetics
--------

Subjects were genotyped for the DISC1 SNPs, Leu607Phe (rs6675281) and Ser704Cys (rs821616) in this study. Genotyping of this polymorphism was performed using a standard 5″ nuclease TaqMan assay-on-demand (Applied Biosystems Inc, Foster City) protocol in a total volume of 10 μL. Postamplification products were analyzed on the ABI 7500 Sequence Detection System (Applied Biosystems), and genotype calls were performed manually. Results were verified independently by two laboratory personnel masked to demographic and phenotypic information. Quality control analysis was performed on 10.0% of the sample.

Magnetic resonance imaging
--------------------------

High-resolution magnetic resonance images were acquired as part of a multimodal imaging protocol using an 8-channel head coil on a 1.5-T GE Echospeed system (General Electric Medical Systems, Milwaukee, WI, USA), which permits maximum gradient amplitudes of 40 mT/m. Axial inversion recovery -- prepared spoiled gradient recall images were acquired: echo time = 5.3 ms; repetition time = 12.3 ms; time to inversion = 300.0 ms; flip angle = 20°; and number of excitations = 1 (for a total of 124 contiguous images, 1.5-mm thickness).

Segmentation of subcortical structures
--------------------------------------

Subcortical structures (striatum, globus, pallidus, and thalamus) were automatically identified using a atlas of the basal ganglia and thalamus derived from serial histological data (Chakravarty et al., [@B8]) and warped to a high-contrast and -resolution neuroanatomical template derived from the average of 27 MRI volumes from the same individual (Holmes et al., [@B33]). The atlas was then customized to the unique neuroanatomy of the subjects being studied using a region-of-interest non-linear registration estimation approach (Chakravarty et al., [@B11], [@B10]) that has been validated against manually defined gold-standards, intra-operative recordings, and brain activations recorded using functional magnetic resonance imaging techniques (Chakravarty et al., [@B11], [@B9],[@B10]). All linear and non-linear transformations were estimated using the ANIMAL algorithm (Collins et al., [@B17], [@B16]; Collins and Evans, [@B15]), which is part of the MINC suite of medical image processing tools[^1^](#fn1){ref-type="fn"}.

Cortical thickness analysis
---------------------------

Cortical thickness was analyzed using the CIVET processing pipeline (version 1.1.10; Montreal Neurological Institute at McGill University, Montreal, QC, Canada). T1-weighted images were registered to the ICBM152 non-linear sixth-generation template with a 9-parameter linear transformation (Collins et al., [@B17]), inhomogeneity corrected (Sled et al., [@B55]) and tissue classified (Zijdenbos et al., [@B62]). Deformable models were then used to create white and gray matter surfaces for each hemisphere separately, resulting in four surfaces of 40,962 vertices each (MacDonald, [@B42]; Kim et al., [@B35]). From these surfaces, the *t*-link metric was derived for determining the distance between the white and gray surfaces (Lerch and Evans, [@B38]). The thickness data were subsequently blurred using a 20-mm surface-based diffusion-blurring kernel in preparation for statistical analyses (Lerch and Evans, [@B38]). Unnormalized, native-space thickness values were used in all analyses owing to the poor correlation between cortical thickness and brain volume. Normalizing for global brain size when it has little pertinence to cortical thickness risks introducing noise and reducing power. A mid-surface (between pial and white matter surfaces) were non-linearly normalized (Robbins et al., [@B51],[@B52]) using a novel depth potential function (Boucher et al., [@B2]) to minimally biased surface template (Lyttelton et al., [@B41]). Where pertinent, all vertex-wise analyses were performed using the RMINC[^2^](#fn2){ref-type="fn"} package and corrected for multiple comparisons using the false-discovery rate (FDR; Genovese et al., [@B21]).

Results
=======

Genotyping yielded 45 LeuLeu homozygotes, 8 PheLeu heterozygotes, and a single PhePhe homozygote for the Leu607Phe genotype. For subsequent neuroimaging anaylses, all Phe carriers were pooled together in the same group yielding 45 LeuLeu homozygotes (18 female and 27 male; mean age: 28.25) and 9 Phe carriers (3 female and 6 male; mean age: 33). For Ser704Cys, genotyping yielded one Ser homozygote, 20 SerCys heterzygotes, and 33 Cys homozygotes. As in the Leu607Phe genotype, we pooled minor allele carrier (i.e., Ser carriers). In subsequent analyses we compared the 21 Ser carriers (9 female and 12 male) to the 33 Cys homozygotes (12 female, 21 male). Neither SNP violated Hardy--Weinberg equilibrium (Leu607Phe: χ^2^ = 0.76, *p = *0.38; Ser704Cys: χ^2^ = 1.08, *p = *0.29).

There were no differences in age, sex, IQ, socio-economic status, and years of education observed based on genotype (see Table [1](#T1){ref-type="table"}).

###### 

**Summary of differences with respect to age, sex, IQ, socio-economic status (SES), and education based on Leu607Phe and Ser704Cys genotypes**.

              Leu607Phe      Ser704Cys                                                 
  ----------- -------------- ------------- --------------- ------------- ------------- --------------
  Age         30.9 (11.1)    34.4 (8.4)    −0.85 (0.398)   33.6 (12.3)   31.9 (9.7)    −0.09 (0.93)
  Sex         3 (6)          19 (25)        0.14 (0.71)    10 (11)       12 (20)        0.53 (0.46)
  IQ          116.0 (12.8)   116.5 (8.0)   −0.19 (0.85)    116.5 (9.0)   116.3 (8.9)    0.08 (0.93)
  SES         46.6 (12.5)    50.0 (8.6)    −1.0 (0.32)     49.2 (10.5)   49.4 (11.5)   −0.08 (0.93)
  Education   15.7 (2.2)     15.3 (1.92)    0.52 (0.61)    14.9 (2.2)    15.6 (1.8)    −1.38 (0.17)

*Sex demographic data given as female (male) and were verified using the χ^2^ statistic. All other results given as mean (standard deviation) and with *t*-values from a two-tailed *t*-test*.

All volumes were analyzed using a linear model that included age and sex. These analyses were performed with and without total brain volume was included as an additional covariate (Table [2](#T2){ref-type="table"} reports values with brain volume included in the statistical model; see also Figure [1](#F1){ref-type="fig"}). For the Leu607Phe genotype, significant increased left and right striatal volume were observed without including brain volumes in the model (left striatum; mean volume, Phe carriers: 10,240 mm^3^, LeuLeu homozygotes: 9043 mm^3^, *t* = 3.06, *p = *0.0036; right striatum mean volume, Phe carriers: 10,167 mm^3^, LeuLeu homozygotes: 8995 mm^3^, *t* = 3.06, *p = *0.0036). The effect of genotype remains significant for both hemispheres when including brain volume in the model (left striatum: *t* = 2.48, *p = *0.017; right: *t* = 2.49, *p = *0.016). No other significant differences were demonstrated for the other subcortical structures (i.e., the globus pallidus or the thalamus). No significant differences were found for any of the subcortical volumes identified for the Ser704Cys genotype.

###### 

**Results from the volumetric analysis, cortical thickness, and surface area for Leu607Phe genotypes**.

                                      Phe carriers (standard error)   LeuLeu homozygotes (standard error)   *t*-Value (*p*-value)
  ----------------------------------- ------------------------------- ------------------------------------- ----------------------------------------------
  **STRIATUM VOLUME (mm^3^)**                                                                               
  Left striatum                       10,240 (374)                    9,043 (124)                           2.48 (0.017)[\*](#tfn1){ref-type="table-fn"}
  Right striatum                      10,167 (268)                    8,995 (121)                           2.49 (0.016)[\*](#tfn1){ref-type="table-fn"}
  **BRAIN VOLUME (mm^3^)**                                                                                  
  Whole brain                         1,426,783 (33,652)              1,345,396 (15,275)                    1.63 (0.10)
  Left hemisphere                     604,272 (15,570)                559,396 (7,094)                       2.80 (0.0074)
  Right hemisphere                    541,537 (14,449)                488,030 (6,583)                       1.71 (0.093)
  **CORTICAL SURFACE AREA (mm^2^)**                                                                         
  Left parietal lobe                  20,434 (542)                    19,028 (246)                          1.82 (0.075)
  Left occipital lobe                 11,891 (416)                    10,945 (190)                          1.71 (0.094)
  Left parasplenium                   642 (38)                        550 (17)                              1.91 (0.062)
  Left insula                         1,645 (57)                      1,524 (26)                            1.67 (0.10)
  Right occipital lobe                12,350 (383)                    11,110 (174)                          2.56 (0.014)
  Right parasplenium                  569 (32)                        502 (15)                              1.68 (0.099)

*\*Total brain volume included in the linear model*.

![**Differences in left and right striatal volume based on the Leu607Phe genotype**. Phe carriers exhibit larger striatal volume bilaterally.](fpsyt-03-00057-g001){#F1}

In our exploratory analyses we found other volume differences based on Leu607Phe genotype. Phe carriers had significantly increased right hemisphere volume in comparison to LeuLeu homozygotes (mean volume, Phe carriers: 1,426,683 mm^3^, LeuLeu homozygotes: 1,345,396mm^3^, *t* = 2.80, *p = *0.0074). Trend-level differences in total brain volume (*t* = 1.63, *p = *0.10) and left hemisphere volume (*t* = 1.71, *p = *0.093) between these groups were also found. Phe carriers had significantly larger surface area in the right occipital lobe (mean surface area, Phe carriers: 12,350 mm^2^, LeuLeu homozygotes: 11,110 mm^2^, *t* = 2.56, *p = *0.014). In addition, trend-level increases in surface area in Phe carriers were observed in the left parietal and right occipital lobes, and bilaterally in the parasplenium (see Table [2](#T2){ref-type="table"}). No vertex-wise differences in cortical thickness or surface area survived comparison for mulitple comparisons at a 5% FDR (Genovese et al., [@B21]) and no structure-wise differences in cortical thickness were observed.

No neuroanatomical differences in volume, cortical thickness, or surface area were observed based on the Ser704Cys genotype.

Discussion
==========

In this manuscript we present an analysis of the relationship between neuroanatomy and two DISC1 SNPs, namely and Leu607Phe andSer704Cys, that have been previously associated with increased risk for mental illness such as schizophrenia (Chubb et al., [@B13]), schizoaffective disorder (Hodgkinson et al., [@B32]), bipolar disorder (Hennah et al., [@B29]), and autism spectrum disorders (Kilpinen et al., [@B34]; Williams et al., [@B61]). We hypothesized that these genotypes would be related to striatal volume as DISC1 has previously been associated with the number of striatal dopamine receptors (Lipina et al., [@B40]). After an analysis of subcortical structures, we found that Phe carriers had larger striatal volume. Further, Phe carrers also exhibited trend-level increases in cortical surface area in comparison to LeuLeu homozygotes (none of which survives a conservative Bonfferroni correction). No volumetric or morphological differences were observed based on Ser704Cys genotype.

To the best of our knowledge, the relationship between striatal volume and DISC1 genotype has not been previously studied. Our finding is in keeping with a 2.1-fold increase in striatal dopamine receptors previously reported in DISC1 mutant mice (Lipina et al., [@B40]), that is consistent with the dopamine hypothesis of schizophrenia. The striatum is one of the brain regions with the highest concentration of D2 receptors. There is a substantial body of evidence supporting dopaminergic dysfunction in schizophrenia, including from *in vivo* positron emission tomography studies of the D2 receptor (Seeman, [@B54]; Heinz and Schlagenhauf, [@B28]). A more refined version of this hypothesis states that the synthesis and availability of the releasable striatal dopamine are increased in patients suffering from schizophrenia (Grunder et al., [@B23]; Guillin et al., [@B24]; Hietala et al., [@B31]), and that dopaminergic activity may be altered in the context of stress (Mizrahi et al., [@B44]).

Previous studies examining the relationship between human neuroanatomy have focused on cortical thickness (Brauns et al., [@B3]; Raznahan et al., [@B49]), gray matter density (Cannon et al., [@B6]), and hippocampal structure (Callicott et al., [@B5]). Raznahan et al. ([@B49])demonstrated decreased thickness in temporal-parietal areas of Phe carriers. In addition, with a longitudinal design, they demonstrated that the rate of cortical thinning in normally developing LeuLeu homozygotes resembled a typical developmental trajectory whereas a more abnormal developmental trajectory was observed in the Phe carriers. Other studies report reduced cortical thickness in the left supra-marginal gyrus (Brauns et al., [@B3]) and reduced gray matter density (Cannon et al., [@B6]) in the dorsolateral prefrontal cortex of Phe carriers. Our analyses showed no cortical thickness differences for either SNP. It is possible that such differences may only be detectable at an earlier time point in the human lifespan, since the study by Raznahan et al. ([@B49]) focuses on a normally developing cohort of adolescents and young adults. The remaining studies on cortical anatomy and DISC1 present conflicting results (Szeszko et al., [@B56]). While our study may have been underpowered to detect cortical thickness changes we do demonstrate that Phe carriers actually have larger brain volume, specifically in the right hemisphere. This relative increase in Phe carrier brain volume may be a reflection of an abnormal developmental process that may, in turn, increase susceptibility to mental illness (Gogtay et al., [@B22]; Paus et al., [@B46]; Raznahan et al., [@B50]).

Our study is also the first to report results related to cortical surface area in DISC1. Cortical volume changes through the course of development can be fractionated into cortical thickness, surface area, and convex hull area subcomponents (Raznahan et al., [@B50]). Further it has been demonstrated that the elements that comprise total brain volume have specific evolutionary (Rakic, [@B47],[@B48]), genetic (Voineskos et al., [@B60], [@B59]), and cellular processes (Chenn and Walsh, [@B12]). Other than the whole brain and hemispheric volume differences reported, no structure-wise volumetric trends were found in our analyses. It is possible that these differences may be related to abnormal development of the cortical manifold that is influenced by DISC1 (as seen in the results for surface area). However, given the fact that results for our surface area findings were no longer significant following multiple comparison correction, our findings should be considered as exploratory.

One of the limitations of the current study is that we did not examine the effects of DISC1 variation in other populations such as ultra high-risk or disease cohorts. Future work in these populations may enable improved prediction of risk of conversion to psychosis, as well as provide insight into phenotypic heterogeneity in disease populations. Another limitation is that reports of heritability of striatal volumes and of alterations of striatal volumes in ultra high-risk subjects are mixed. (Ettinger et al., [@B18]) have demonstrated no differences in striatal volumes between UHR subjects that convert and those that do not convert to a form of psychosis (Hannan et al., [@B26]) or in monozygotic twins discordant for psychosis (Ettinger et al., [@B18]). Groups that rely on manual tracing either omit portions of the striatum (the tail of the caudate; Hannan et al., [@B26]) or define volumes using sub-sampled MRI image volumes (to facilitate manual labeling using stereology-based techniques). In both these cases, one cannot expect the accuracy of the manual labeling to be as consistent as an automated segmentation technique that has been shown to have lower variability than manual raters (Chakravarty et al., [@B10]). Furthermore, there is evidence in the UHR literature that supports our findings. For instance, larger caudate nucleus volumes were demonstrated in a study of non-psychotic UHR individuals who are members of a multicomplex families where at least one parent suffers from psychosis (Hajek et al., [@B25]). In addition, studies of patients with schizotypal personality disorders, where medication confounds are not present, also support alterations of striatal volumes in schizophrenia spectrum disorders (Koo et al., [@B36]; Levitt et al., [@B39]).

Other groups have also demonstrated neuroanatomical differences in brain morphology based on the Ser704Cys variant. We show no such differences in the striatal volumes or the other cortical measures. One interpretation of these results is that only the Leu607Phe variant influences striatal anatomy. On the other hand, it is also possible that we may simply be underpowered to detect subtle changes related to Ser704Cys genotype that others have found (Cannon et al., [@B6]; Brauns et al., [@B3]; Raznahan et al., [@B49]). One of the more robust findings of morphological differences that were shown to be associated with the Ser704Cys genotype occurred in a cohort of healthy developing younger individuals (Raznahan et al., [@B49]), suggesting that the strength of this relationship may change across the course of brain development.

This is the first paper demonstrating a potential role for DISC1 in human striatal structure. Further, there are now converging lines of evidence from both animal and human studies that confirm this role. We have delineated this new pathway using an imaging-genetics analysis approach and have demonstrated how DISC1 confers risk for severe mental illness through the striatum. Further research is required to better understand the link between DISC1 and the striatal deficits reported in this article and cortical deficits previously described.
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